Immunotherapy has the potential to provide an alternative and/or complementary treatment for most types of cancer. The advantage of immunotherapy over radiation and chemotherapy is that it can act specifically against the tumor without causing normal tissue damage. Unfortunately the immune system by itself can´t recognize these malignant cells and destroy them, however recent advances have revealed that certain proteins binding with specific tumor antigens can be recognized by the immune system.

Our immune protein booster – IPF, works by binding to these tumor antigens, creating what is known as “superantigens” this makes our body recognize the malignant cells and destroy them by:

• Increasing the number of antibodies to attack the cancer cells
• Inducing a potent T-cell immune response against the cancer cells.

Read more about how IPF works for cancer here.